Search results
FDA grants breakthrough status to Soleno's PWS drug By Investing.com
Investing.com· 2 days agoSoleno Therapeutics, Inc. (NASDAQ: NASDAQ:SLNO) has received Breakthrough Therapy Designation from...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 20 hours agoJacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint PR Newswire BEIJING and SHANGHAI and BOSTON, April 30, 2024 BEIJING and SHANGHAI and BOSTON, April 30, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced that the
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 7 days agoShanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly...
CW39 NewsFix· 5 days agoSobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for ...
KEEP & PANTHERx Rare Forge Innovative Partnership to Advance the Specialty Therapy Experience in the...
FOX 4 Kansas City· 6 days agoAn exciting advancement for the specialty pharmacy industry, KEEP announced a strategic partnership...
NovAccess Global Announces New License to Advance its Immunotherapy Platform
Digital Journal· 1 day agoCLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous ...
Jaguar Health, Inc.
San Mateo Daily Journal· 2 days agoJaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
FOX21 Colorado Springs· 11 hours agoAmgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International Conference taking place May 12-22 in San Diego. "We look ...
CIRM Awards $11.8 Million Grant for Clinical Trial in High-Grade Glioma Including Glioblastoma Using...
Fontana Herald News· 1 day agoDenovo Biopharma LLC (Denovo), a pioneer in applying precision medicine to the development of innovative therapies, today announced that the California Institute for Regenerative Medicine (CIRM ...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma -...
Benzinga· 2 days agoNEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, announced today that the first patient in its Phase
